Blocking the MLK3-PIAS3 interaction inhibits MLK3 SUMOylation and stimulation, alleviates neuronal injury and cognitive impairment, and plays a neuroprotective role after cerebral ischemia. The gene discussed is MAP3K11; the disease is brain ischemia.